Cargando…
HOXD3 was negatively regulated by YY1 recruiting HDAC1 to suppress progression of hepatocellular carcinoma cells via ITGA2 pathway
OBJECTIVES: HOXD3 is associated with progression of multiple types of cancer. This study aimed to identify the association of YY1 with HOXD3‐ITGA2 axis in the progression of hepatocellular carcinoma. MATERIALS AND METHODS: Bioinformatics assay was used to identify the effect of YY1, HOXD3 and ITGA2...
Autores principales: | Wang, Lumin, Gao, Yi, Zhao, Xiaoge, Guo, Chen, Wang, Xiaofei, Yang, Yang, Han, Cong, Zhao, Lingyu, Qin, Yannan, Liu, Liying, Huang, Chen, Wang, Wenjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445403/ https://www.ncbi.nlm.nih.gov/pubmed/32557953 http://dx.doi.org/10.1111/cpr.12835 |
Ejemplares similares
-
A pan-cancer analysis of the role of HOXD1, HOXD3, and HOXD4 and validation in renal cell carcinoma
por: Wang, Lumin, et al.
Publicado: (2023) -
MeCP2 drives hepatocellular carcinoma progression via enforcing HOXD3 promoter methylation and expression through the HB‐EGF/EGFR pathway
por: Wang, Lumin, et al.
Publicado: (2021) -
HOXD3 targeted by miR-203a suppresses cell metastasis and angiogenesis through VEGFR in human hepatocellular carcinoma cells
por: Wang, Lumin, et al.
Publicado: (2018) -
EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway
por: Wang, Lumin, et al.
Publicado: (2016) -
YY1 promotes HDAC1 expression and decreases sensitivity of hepatocellular carcinoma cells to HDAC inhibitor
por: Dong, Sheng, et al.
Publicado: (2017)